Am J Transplant, Volume 18, Suppl 3 Archives - Page 171 of 211 - ATC Abstracts

2018 American Transplant Congress
Outcomes in Liver Transplant Patients on Renal Sparing Protocol
A. Polyak,¹ D. Ganger,² A. Shetty.²
¹New York Medical College, Valhalla, NY; ²Comprehensive Transplant Center, Northwestern University, Chicago, IL.
As liver transplant outcomes have improved, long term native kidney function has taken a critical role in patient survival. Calcineurin inhibitors (CNIs), such as Tacrolimus…
2018 American Transplant Congress
Living Liver Donors Face Substantial Out-of-Pocket Donation-Related Costs
J. Ruck, A. Massie, J. Garonzik-Wang, S. Ottman, A. Cameron, B. Philosophe, D. Segev.
Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
While financial barriers to living kidney donation have been recognized, and the associated costs have been characterized limited data exist on the costs incurred by…
2018 American Transplant Congress
Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction
S. Patel, J. Jin, E. Benedetti, P. West-Thielke.
University of Illinois Hospital and Health Sciences System, Chicago.
Background: Hepatitis C virus (HCV) recurrence after orthotopic liver transplant (OLT) is universal and exhibits accelerated progression to cirrhosis. Progression can be mitigated by new…
2018 American Transplant Congress
The Technique of Ileobladder and Kidney Transplantation in Rats and Pigs
M. Haberal,¹ M. Kirnap,¹ D. Ersoz,¹ D. Bacanli,² Z. Ersoy,³ M. Bayzakov,¹ A. Torgay,³ H. Ozdemir.⁴
¹Transplantation, Baskent University, Ankara, Turkey; ²Research Center, Baskent University, Ankara, Turkey; ³Anesthesiology, Baskent University, Ankara, Turkey; ⁴Pathology, Baskent University, Ankara, Turkey.
Introduction: Small, poor compliant or unstable bladders are a major problem in patients waiting for renal transplantation (RT). The experimental technique aims to develop and…
2018 American Transplant Congress
Maximizing Utilization in Pancreas Transplantation: Phenotypic CharacteristicsDifferentiating Aggressive from Nonaggressive Transplant Centers
O. K. Serrano,¹ D. M. Vock,² T. B. Dunn,¹ R. Kandaswamy,¹ E. B. Finger.¹
¹Surgery, University of Minnesota, Minneapolis, MN; ²Biostatistics, University of Minnesota, Minneapolis, MN.
OBJECTIVE: Given the increasing shortage of deceased donor pancreas allografts and their declining acceptance rate, maximizing utilization requires a balance between donor selection and transplant…
2018 American Transplant Congress
Phosphoproteomic Analysis of Mouse Hepatic Ischemia/Reperfusion Injury
A. Zarrinpar,² S. Duarte,¹ Y. Lai.²
¹Surgery, University of California, Los Angeles, CA; ²Surgery, University of Florida, Gainesville, FL.
Introduction: Hepatic ischemia/reperfusion injury (IRI) is a major risk factor for acute rejection and early graft dysfunction in liver transplantation. The large and complex landscape…
2018 American Transplant Congress
Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes
S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.
¹Saarland University, Homburg/Saar, Germany; ²Saarland University, Homburg/Saar, Germany.
Background: Dosage of immunosuppressive drugs in transplant patients must be balanced to prevent graft rejection and infectious complications. Knowledge on general immune function may therefore…
2018 American Transplant Congress
Ultra Low Dose of IL-2 Produces Long-Term Drug-Free Survival of Cynomolgus Islets Allografts
M. Koulmanda,¹ V. Chipashivili,¹ L. Li,¹ M. Duggan,² T. Strom.¹
¹Medicine and Surgery, Beth Israel Deaconess Medical Center, Boston, MA; ²Surgery, MGH, Boston, MA.
Therapeutic principles established in non-human transplant models have value for clinical application despite cost related limitations on sample size. We have tested new therapies in…
2018 American Transplant Congress
Impact of the New Kidney Allocation System A2/A2B –> B Policy on Access to Transplantation among Minority Candidates
M. Mustian,¹ P. Martins,² P. MacLennan,¹ J. Ortiz,² J. Caicedo,² S. Gray,^1,2 B. Kelly,² C. Esquivel,² ASTS Diversity Affairs Commmittee,² J. Locke.^1,2
¹University of Alabama at Birmingham, Birmingham; ²ASTS Diversity Affairs Committee, Arlington.
Introduction: Blood group B kidney transplant candidates, many of whom represent ethnic minorities, have historically had diminished access to deceased donor kidney transplantation (DDKT). However,…
2018 American Transplant Congress
Impacts of HBsAg Seropositive Status on Patient and Graft Survival after Kidney Transplantation in the Era of New Antiviral Therapy: A Meta-Analysis
N. Leeaphorn,¹ C. Thongprayoon,² K. Sharma,² A. Sakhuja,³ W. Cheungpasitporn.⁴
¹Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA; ²Department of Medicine, Bassett Medical Center, Cooperstown, NY; ³Department of Medicine, Mayo Clinic, Rochester, MN; ⁴Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS.
BACKGROUND: An association between HBsAg seropositive status and increased mortality after kidney transplantation has been demonstrated in previous studies over the past decade. Although chronic…